The size of the market for pyrogen testing was estimated at USD 1.03 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.95% from 2024 to 2030, or USD 2.55 billion.
Key factors driving the pyrogen testing market growth over the forecast spell include rapidly rising biotechnology & pharmaceutical sectors as well as rapidly increasing pharmaceutical and biotechnology industries and augmenting number of innovative biologics products launch. For example, the number of innovative biologics products launched each year saw a strong ascendant trend in the middle of 2003 and 2013. Additionally, number of new products launched in the year 2013 was somewhere seen to be 56 as compared to 29 in the years 2003.
The global market of pyrogen testing has been segmented by different applications, products, tests and geography. Furthermore, application segment of the market is sub-divided into medical devices manufacturing, pharmaceuticals & biologicals manufacturing and other applications including water purification, food & beverages, cosmetics and plastics & glass products. Amongst these, the pharmaceuticals & biologicals manufacturing section of the segment accounted for the highest pyrogen testing market share in 2017, owing to the speedy growth in pharmaceutical & biotechnology businesses.
Further, test segments of the pyrogen testing market is sub-segmented into LAL (Limulus Amebocyte Lysate) test, vitro pyrogen test and Rabbit test. LAL (Limulus amebocyte lysate) test section of the segment dominates the market with major share. Likewise, product segment of the market is bifurcated into kits & reagents and Instruments. Kits & reagents section of segment led with highest pyrogen testing market share. This is mainly due to repeat purchase of kits & reagents and increasing adoption of kit-based testing. Geographically, global pyrogen testing market is divided into several key regions including Asia-Pacific, Europe, North America and the Rest of the World (RoW).
Some of the Key players operating in the competitive edge of pyrogen testing market across the globe include Hyglos GmbH, Charles River Laboratories International Inc., Lonza Group, Associates of Cape Cod Inc., Merck KGaA, Genscript, Sanquin, Wako Chemicals and WuXi PharmaTech (Cayman), Inc. Moreover, prominent players focus over using animal-free pyrogen testing that will enable replacing rabbit pyrogen testing over the forecast spell.
Pyrogen Testing Market Scope
Metrics | Details |
Base Year | 2023 |
Historic Data | 2018-2022 |
Forecast Period | 2024-2030 |
Study Period | 2018-2030 |
Forecast Unit | Value (USD) |
Revenue forecast in 2030 | USD 2.55 billion |
Growth Rate | CAGR of 11.95 % during 2020-2030 |
Segment Covered | By Recombinant Factor, Rabbit Pyrogen Test Type, Regions |
Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
Key Players Profiled | Charles River Laboratories (US), Lonza (Switzerland), Merck KGaA (Germany), Ellab A/S (Denmark), GenScript (US), Hyglos (Germany), Thermo Fisher Scientific Inc. (US), Wako USA (US), WuXi AppTec (China), Associates of Cape Cod, Inc. (US), Sanquin (Netherlands), Minerva Analytix GmbH (Germany), InvivoGen (US), Microcoat Biotechnologie GmbH (Germany), North American Science Associates, Inc (US), Creative Bioarray (US) and INDOOR Biotechnologies, Inc. (India), among others |
Key segments of global pyrogen testing market include:
Applications Segment of pyrogen testing market
- Medical devices manufacturing
- Pharmaceuticals & biologicals manufacturing
- other applications
- Water purification
- Food & beverages
- Cosmetics
- Plastics & glass products
Tests Segment of pyrogen testing market
- LAL (Limulus Amebocyte Lysate) test
- Vitro pyrogen test
- Rabbit test
Products Segment of pyrogen testing market
- Kits & reagents
- Instruments
Geographical segmentation of pyrogen testing market
- Asia-Pacific
- Europe
- North America
- The Rest of the World (RoW).